Pascal Grondin
Overview
Explore the profile of Pascal Grondin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
491
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Foretz M, Ancellin N, Andreelli F, Saintillan Y, Grondin P, Kahn A, et al.
Diabetes
. 2005 Apr;
54(5):1331-9.
PMID: 15855317
AMP-activated protein kinase (AMPK) is a major therapeutic target for the treatment of diabetes. We investigated the effect of a short-term overexpression of AMPK specifically in the liver by adenovirus-mediated...
12.
Daugan A, Grondin P, Ruault C, Le Monnier de Gouville A, Coste H, Linget J, et al.
J Med Chem
. 2003 Oct;
46(21):4533-42.
PMID: 14521415
Modification of the hydantoin ring in the previously described lead compound 2a has led to the discovery of compound 12a, tadalafil, a highly potent and highly selective PDE5 inhibitor. The...
13.
Daugan A, Grondin P, Ruault C, Le Monnier de Gouville A, Coste H, Kirilovsky J, et al.
J Med Chem
. 2003 Oct;
46(21):4525-32.
PMID: 14521414
Starting from ethyl beta-carboline-3-carboxylate (beta-CCE), 1, a modest inhibitor of type 5 phosphodiesterase (PDE5), a series of functionalized tetrahydro-beta-carboline derivatives has been identified as a novel chemical class of potent...